DEUTSCHE BANK AG\ - CYCLACEL PHARMACEUTICALS INC ownership

CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 19 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$01,286
+1038.1%
0.00%
Q4 2018$0113
+3666.7%
0.00%
Q3 2018$030.0%0.00%
Q2 2018$0
-100.0%
3
-99.9%
0.00%
Q4 2017$4,0002,803
+457.3%
0.00%
Q3 2017$0
-100.0%
503
-79.1%
0.00%
Q2 2017$9,0002,403
+80000.0%
0.00%
Q1 2017$030.0%0.00%
Q4 2016$0
-100.0%
3
-99.9%
0.00%
Q3 2016$15,0002,603
+86666.7%
0.00%
Q2 2016$030.00%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 559,900$1,025,0000.31%
Virtu Financial LLC 117,644$215,0000.01%
WEDBUSH SECURITIES INC 27,400$50,0000.01%
TWO SIGMA SECURITIES, LLC 28,471$52,0000.01%
BREWIN DOLPHIN LTD 5,586$10,2220.00%
UBS Group AG 3,355$6,0000.00%
D'Orazio & Associates, Inc. 100$00.00%
DIMENSIONAL FUND ADVISORS LP 14,749$27,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 21,692$39,0000.00%
DEUTSCHE BANK AG\ 503$00.00%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders